Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial

被引：0
|
作者：
Nathan, S. D. [1 ]
Tapson, V. F. [2 ]
Elwing, J. M. [3 ]
Rischard, F. P. [4 ]
Mehta, J. P. [5 ]
Shapiro, S. [6 ]
Shen, E. [7 ]
Edwards, L. [7 ]
Smith, P. M. [7 ]
Waxman, A. B. [8 ]
机构：
[1] Inova Fairfax Hosp, Falls Church, VA USA
[2] Cedars Sinai, Pulm, W Hollywood, CA USA
[3] Univ Cincinnati, Pulm CCM & Sleep, Cincinnati, OH USA
[4] Univ Arizona, Div Pulm & Crit Care, Tucson, AZ USA
[5] Cleveland Clin Florida, Pulm, Weston, FL USA
[6] VA Hosp, Cardiol, Los Angeles, CA USA
[7] United Therapeut, Res Triangle Pk, NC USA
[8] Brigham & Womans Hosp, Pulm Crit Care Med, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1027
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, Steven D.
    Tapson, Victor F.
    Elwing, Jean
    Rischard, Franz
    Mehta, Jinesh
    Shapiro, Shelley
    Shen, Eric
    Deng, Chunqin
    Smith, Peter
    Waxman, Aaron
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 198 - +
  • [2] Efficacy in Patient Subgroups in the INCREASE Trial, a Phase III Trial to Evaluate Inhaled Treprostinil in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease
    Tapson, Victor
    Nathan, Steven
    Girgis, Reda
    Runo, James
    Bag, Remzi
    Talwar, Arunabh
    Smith, Peter
    Edwards, Lisa
    Park, Christine
    Waxman, Aaron
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1030 - 1032
  • [3] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [4] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    [J]. LUNG, 2018, 196 (02) : 139 - 146
  • [5] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    [J]. Lung, 2018, 196 : 139 - 146
  • [6] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
  • [7] Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
    West, Natalie
    Smoot, Karen
    Patzlaff, Natalie
    Miceli, Melissa
    Waxman, Aaron
    [J]. FUTURE CARDIOLOGY, 2023, 19 (05) : 229 - 239
  • [8] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    [J]. CHEST, 2021, 160 (04) : 2244A - 2246A
  • [9] Safety and tolerability of inhaled treprostinil with phosphodiesterase-5 inhibitors in patients with pulmonary hypertension due to interstitial lung disease
    Zisman, David
    Dubrock, Hilary
    King, Christopher
    Weaver, Sheila
    Nathan, Steven
    Rahaghi, Franck
    Kim, Hyoshin
    Rao, Youlan
    Shen, Eric
    Waxman, Aaron
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension
    Nathan, S.
    Argula, R.
    Rajagopal, S.
    Johri, S.
    De La Zerda, D.
    Mcglothlin, D.
    Smith, P.
    Deng, C.
    Miceli, M.
    Tapson, V
    Waxman, A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345